Recent Quarter Total Invested
$1.79 B
Recent Quarter Institutional Ownership Percentage
102.45%
Total Invested of Last Quarter
$2.15 B
Ownership Percentage of Last Quarter
124.43%
Syndax Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK INC. | 08/13/2024 | 7.91 M | $162.33 M | 4.69% | 9.28% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2024 | 7.34 M | $150.67 M | -1.31% | 8.61% |
| KYNAM CAPITAL MANAGEMENT, LP | 08/14/2024 | 5.72 M | $117.47 M | 1.10% | 6.72% |
| VANGUARD GROUP INC | 08/13/2024 | 4.80 M | $98.48 M | -2.64% | 5.63% |
| AVORO CAPITAL ADVISORS LLC | 08/14/2024 | 3.89 M | $79.83 M | -7.91% | 4.56% |
| STATE STREET CORP | 08/14/2024 | 3.62 M | $74.37 M | -24.84% | 4.25% |
| EVERSEPT PARTNERS, LP | 08/14/2024 | 3.61 M | $74.19 M | 15.34% | 4.24% |
| AVIDITY PARTNERS MANAGEMENT LP | 08/14/2024 | 3.34 M | $68.47 M | 38.24% | 3.91% |
| POINT72 ASSET MANAGEMENT, L.P. | 09/16/2024 | 2.78 M | $57.13 M | 34.65% | 3.27% |
| SOFINNOVA INVESTMENTS, INC. | 08/09/2024 | 2.15 M | $44.21 M | 33.89% | 2.53% |
| ORBIMED ADVISORS LLC | 08/14/2024 | 1.93 M | $39.53 M | 10.08% | 2.26% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 1.91 M | $39.23 M | 7.43% | 2.24% |
| MARSHALL WACE, LLP | 08/14/2024 | 1.83 M | $37.58 M | -9.92% | 2.15% |
| FRANKLIN RESOURCES INC | 08/14/2024 | 1.56 M | $31.93 M | 3.98% | 1.83% |
| WOODLINE PARTNERS LP | 08/14/2024 | 1.55 M | $31.73 M | 0.08% | 1.81% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 1.44 M | $29.65 M | 10.22% | 1.69% |
| STEMPOINT CAPITAL LP | 08/13/2024 | 1.41 M | $28.99 M | 28.26% | 1.66% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 1.07 M | $21.87 M | 56.26% | 1.25% |
| AISLING CAPITAL MANAGEMENT LP | 08/08/2024 | 1.03 M | $21.04 M | 0.00% | 1.20% |
| CANDRIAM S.C.A. | 08/05/2024 | 970,106 | $19.92 M | -7.17% | 1.14% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 930,947 | $19.11 M | 29.56% | 1.09% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 08/14/2024 | 894,993 | $18.37 M | 0.00% | 1.05% |
| FORESITE CAPITAL MANAGEMENT IV, LLC | 08/13/2024 | 875,000 | $17.96 M | 0.00% | 1.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2024 | 860,000 | $17.66 M | -4.44% | 1.01% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 852,206 | $17.50 M | -48.51% | 1.00% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 08/14/2024 | 826,500 | $16.97 M | 123.98% | 0.97% |
| COMMODORE CAPITAL LP | 08/14/2024 | 825,000 | $16.94 M | 158.74% | 0.97% |
| SPHERA FUNDS MANAGEMENT LTD. | 08/14/2024 | 822,047 | $16.88 M | 1.12% | 0.96% |
| MORGAN STANLEY | 10/17/2024 | 756,232 | $15.53 M | -58.35% | 0.89% |
| NORTHERN TRUST CORP | 08/14/2024 | 696,729 | $14.30 M | -6.08% | 0.82% |
| DAFNA CAPITAL MANAGEMENT LLC | 08/14/2024 | 657,074 | $13.49 M | -0.38% | 0.77% |
| FEDERATED HERMES, INC. | 08/08/2024 | 656,250 | $13.47 M | 21.82% | 0.77% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 654,489 | $13.44 M | 3.04% | 0.77% |
| FIRST TURN MANAGEMENT, LLC | 08/08/2024 | 640,389 | $13.15 M | 100.00% | 0.75% |
| JPMORGAN CHASE & CO | 08/12/2024 | 629,880 | $12.93 M | -7.71% | 0.74% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 08/13/2024 | 625,723 | $12.85 M | 118.53% | 0.73% |
| TWO SIGMA ADVISERS, LP | 08/14/2024 | 621,252 | $12.75 M | 36.28% | 0.73% |
| PARKMAN HEALTHCARE PARTNERS LLC | 08/14/2024 | 600,698 | $12.33 M | -23.46% | 0.70% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 08/14/2024 | 594,386 | $12.20 M | 49.77% | 0.70% |
| NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 556,414 | $11.42 M | 41.69% | 0.65% |
| PROSIGHT MANAGEMENT, LP | 08/14/2024 | 551,544 | $11.32 M | 100.00% | 0.65% |
| AMERIPRISE FINANCIAL INC | 08/14/2024 | 521,080 | $10.70 M | 1.87% | 0.61% |
| ENSIGN PEAK ADVISORS, INC | 08/13/2024 | 518,885 | $10.65 M | 0.78% | 0.61% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 08/20/2024 | 453,232 | $9.30 M | -2.59% | 0.53% |
| ALGERT GLOBAL LLC | 08/15/2024 | 432,128 | $8.87 M | 1.52% | 0.51% |
| ASSENAGON ASSET MANAGEMENT S.A. | 07/18/2024 | 428,949 | $8.81 M | 54.34% | 0.50% |
| SATURN V CAPITAL MANAGEMENT LLC | 08/14/2024 | 419,654 | $8.62 M | 5.44% | 0.49% |
| PALO ALTO INVESTORS LP | 08/14/2024 | 405,193 | $8.32 M | 0.00% | 0.48% |
| PFM HEALTH SCIENCES, LP | 08/14/2024 | 387,357 | $7.95 M | -41.19% | 0.45% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 08/14/2024 | 370,000 | $7.60 M | 100.00% | 0.43% |
Syndax Pharmaceuticals, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of SNDX shares?
During the previous two years, 240 institutional investors and hedge funds held shares of Syndax Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 8.24 M
Kynam Capital Management, LP: 5.84 M
WELLINGTON MANAGEMENT GROUP LLP: 4.99 M
Eversept Partners, LP: 4.11 M
Avoro Capital Advisors LLC: 3.89 M
STATE STREET CORP: 3.77 M
-
What percentage of Syndax Pharmaceuticals, Inc. stock is owned by institutional investors?
102.45% of Syndax Pharmaceuticals, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at SNDX ?
Institutional investors have bought a total of 91.59 M shares in the last 24 months. This purchase volume represents approximately $1.47 B in transactions.